Joy Ignacio
Family · Redding, CANPI 1134517667
Payments from drug & device makers
Across 262 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$846
- Novo Nordisk$702
- AbbVie$358
- Boehringer Ingelheim$308
- Pfizer$286
- Exact Sciences$209
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,843100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 42 | $846 |
| Novo Nordisk | 38 | $702 |
| AbbVie | 20 | $358 |
| Boehringer Ingelheim | 17 | $308 |
| Pfizer | 19 | $286 |
| Exact Sciences | 8 | $209 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $184 |
| Amgen | 10 | $174 |
| GSK | 7 | $157 |
| Hologic Sales And Service, LLC | 7 | $155 |
| Alk-abello, Inc | 8 | $146 |
| AstraZeneca | 8 | $136 |
| Novartis | 6 | $131 |
| Merck | 7 | $123 |
| Gilead | 5 | $112 |
| Astellas Pharma US Inc | 6 | $108 |
| BD | 4 | $95 |
| Biohaven Pharmaceuticals, Inc. | 5 | $83 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $82 |
| Cranial Technologies, Inc | 6 | $74 |
| Johnson & Johnson | 3 | $62 |
| Qiagen, LLC | 2 | $44 |
| Phadia US Inc. | 2 | $40 |
| VBI Vaccine (delaware) Inc. | 3 | $37 |
| Amarin Pharma, Inc. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $26 |
| Bayer | 1 | $21 |
| Shield Therapeutics Inc | 1 | $20 |
| Edwards Lifesciences | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Organon | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$107
How this compares
$4,843 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 61 | $45,385 |
| TradjentaLinagliptin | 54 | $40,584 |
| MounjaroTirzepatide | 27 | $27,760 |
| RybelsusSemaglutide | 15 | $19,771 |
| JanuviaSitagliptin Phosphate | 23 | $18,419 |
| EliquisApixaban | 18 | $13,567 |
| XareltoRivaroxaban | 15 | $13,278 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 30 | $7,636 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 110 | $3,459 |
| Celecoxib | 59 | $3,212 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $3,061 |
| Atorvastatin Calcium | 470 | $2,374 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 32 | $2,136 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $1,996 |
| Paliperidone ErPaliperidone | 11 | $1,638 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $308 | $85,969115 claims |
| Lilly USA, LLCMounjaro, Olanzapine | $846 | $28,51568 claims |
| Novo NordiskRybelsus | $702 | $19,77115 claims |
| MerckJanuvia | $123 | $18,41923 claims |
| PfizerEliquis | $286 | $13,56718 claims |
| Johnson & JohnsonXarelto | $62 | $13,27815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in Redding
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.